Archives life-sciences+life-sciences

by in
Entry Author Date Location
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
Avitide Gets $7.6M More to Purify Complex Biologics 08/06/15 Boston
FDA Taps DNAnexus to Build Platform for Crowdsourcing Diagnostics 08/05/15 National
In Tough Diagnostics World, Will Ruling Out Cancer Be Good Business? 08/04/15 National
Shire Snaps up New York’s Foresight Bio in $300M Pink Eye Deal 08/03/15 New York
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
Synergy Hits Mark on Second Trial, Eyes Approval For Constipation Drug 07/30/15 New York
Foresite Capital Keeps Late-Stage Healthcare Focus With $450M Third Fund 07/29/15 San Francisco
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
Healthtech Startup ConsortiEX Closes $1M Round Led By Open Prairie 07/27/15 Wisconsin
Beer Out as Struggling Aegerion Shuffles Leadership Ranks 07/27/15 Boston
FDA OKs Cholesterol Fighter Praluent For More Patients Than Expected 07/24/15 New York
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
Ginkgo Bioworks Adds $45M to Expand Organism Engineering 07/23/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
With New Alzheimer’s Data, Biogen Refines Plans For Big Trial 07/22/15 Boston
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past 07/15/15 Boston
Celgene to Acquire San Diego’s Receptos for $7.2B in Cash 07/14/15 San Diego
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
The Near Death, and Second Life, of Cerulean Pharma 07/13/15 Boston
EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials 07/10/15 Boston
21st Century Cures Act Passes House, Now Must Navigate Senate 07/10/15 National
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
Page 2 of 99 « previous page · next page »